Keros Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2024 | 4.90 M | $284.49 M | 3.80% | 13.57% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.63 M | $152.88 M | 100.00% | 7.29% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.90 M | $110.19 M | 18.68% | 5.26% |
| VANGUARD GROUP INC | 11/13/2024 | 1.86 M | $107.80 M | 5.65% | 5.14% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 11/14/2024 | 1.52 M | $88.48 M | -0.14% | 4.22% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.51 M | $87.95 M | 27.49% | 4.19% |
| STATE STREET CORP | 11/14/2024 | 1.11 M | $64.67 M | -8.83% | 3.08% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.02 M | $59.16 M | -19.70% | 2.82% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 947,570 | $55.03 M | 155.86% | 2.62% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 879,344 | $51.06 M | 0.00% | 2.44% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 866,737 | $50.33 M | -3.60% | 2.40% |
| HOLOCENE ADVISORS, LP | 11/14/2024 | 843,110 | $48.96 M | 22.49% | 2.34% |
| WOODLINE PARTNERS LP | 11/14/2024 | 763,548 | $44.34 M | -1.59% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 725,621 | $42.15 M | 6.77% | 2.01% |
| BRAIDWELL LP | 11/14/2024 | 707,240 | $41.07 M | -28.00% | 1.96% |
| CITADEL ADVISORS LLC | 11/14/2024 | 704,923 | $40.93 M | 71.73% | 1.95% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 572,990 | $33.27 M | 45.82% | 1.59% |
| REDMILE GROUP, LLC | 11/14/2024 | 552,506 | $32.08 M | 0.00% | 1.53% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 525,037 | $30.49 M | 100.00% | 1.45% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 445,068 | $25.85 M | -18.92% | 1.23% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 421,782 | $24.49 M | 112.35% | 1.17% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 395,276 | $22.95 M | 7.56% | 1.09% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 381,659 | $22.16 M | 0.75% | 1.06% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 380,000 | $22.07 M | -23.88% | 1.05% |
| MORGAN STANLEY | 11/14/2024 | 365,297 | $21.21 M | 8.83% | 1.01% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 355,664 | $20.65 M | -31.79% | 0.99% |
| CANDRIAM S.C.A. | 11/13/2024 | 345,384 | $20.06 M | -21.83% | 0.96% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 325,434 | $18.90 M | 267.16% | 0.90% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 297,669 | $17.29 M | -0.17% | 0.82% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 293,200 | $17.03 M | -14.57% | 0.81% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 288,234 | $17.44 M | -27.98% | 0.80% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2024 | 287,484 | $16.69 M | 100.00% | 0.80% |
| MANGROVE PARTNERS | 11/14/2024 | 286,995 | $16.67 M | 100.00% | 0.79% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 261,348 | $15.18 M | 142.48% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 260,120 | $15.11 M | 14.27% | 0.72% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 224,600 | $13.04 M | 1.35% | 0.62% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 223,704 | $12.99 M | 814.61% | 0.62% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 200,000 | $11.61 M | 135.29% | 0.55% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 199,354 | $11.58 M | 484.39% | 0.55% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 187,500 | $10.89 M | 0.00% | 0.52% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 186,288 | $10.82 M | 6.03% | 0.52% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 171,170 | $9.94 M | 205.13% | 0.47% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 171,071 | $9.93 M | -4.43% | 0.47% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 161,130 | $9.36 M | 11.14% | 0.45% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 158,205 | $9.19 M | 5.15% | 0.44% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 155,545 | $9.03 M | 100.00% | 0.43% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 152,436 | $8.85 M | -5.74% | 0.42% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 122,633 | $7.12 M | -22.20% | 0.34% |
| WCM INVESTMENT MANAGEMENT, LLC | 11/04/2024 | 113,860 | $6.43 M | -2.30% | 0.32% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 112,613 | $6.54 M | 100.00% | 0.31% |
Keros Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 172 institutional investors and hedge funds held shares of Keros Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 4.9 M
BlackRock Funding, Inc. /DE: 2.63 M
ALKEON CAPITAL MANAGEMENT LLC: 1.9 M
VANGUARD GROUP INC: 1.86 M
Darwin Global Management, Ltd.: 1.52 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.51 M
96.73% of Keros Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 37.31 M shares in the last 24 months. This purchase volume represents approximately $448.47 M in transactions.